Transcriptional regulation of the IL-23/IL-17 immune axis during CNS autoimmune inflammation

被引：0
|
作者：
Cua, Daniel J. [1 ]
机构：
[1] DNAX Res, Schering Plough Biopharma, Palo Alto, CA 94304 USA
来源：
JOURNAL OF NEUROIMMUNOLOGY | 2006年 / 178卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：33 / 34
页数：2
相关论文
共 50 条
  • [21] IL-23 and IL-17 in tuberculosis
    Khader, Shabaana A.
    Cooper, Andrea M.
    CYTOKINE, 2008, 41 (02) : 79 - 83
  • [22] Reconsidering the role of the IL-23/IL-17 immune axis in idiopathic nephrotic syndrome pathogenesis
    Salfi, Giuseppe
    CLINICAL KIDNEY JOURNAL, 2024, 17 (01)
  • [23] Role of the IL-23/IL-17 Axis in Crohn's Disease
    Siakavellas, Spyros I.
    Bamias, Giorgos
    DISCOVERY MEDICINE, 2012, 14 (77) : 253 - 262
  • [24] IL-23/IL-17 axis in spondyloarthritis-bench to bedside
    Siba P. Raychaudhuri
    Smriti K. Raychaudhuri
    Clinical Rheumatology, 2016, 35 : 1437 - 1441
  • [25] IL-23/IL-17 axis in spondyloarthritis-bench to bedside
    Raychaudhuri, Siba P.
    Raychaudhuri, Smriti K.
    CLINICAL RHEUMATOLOGY, 2016, 35 (06) : 1437 - 1441
  • [26] CD109 is a key regulator of the IL-23/IL-17 immune axis in the skin
    Carnevale, G.
    Fontes, G.
    King, I.
    EXPERIMENTAL DERMATOLOGY, 2016, 25 : 17 - 18
  • [27] Immune checkpoint protein VISTA is a critical regulator of the IL-23/IL-17 inflammatory axis
    Li, Na
    Xu, Wenwen
    Yuan, Ying
    Ayithan, Natarajan
    Imai, Yasutomo
    Wu, Xuesong
    Miller, Halli
    Olson, Michael
    Hwang, Samuel T.
    Malarkannan, Subramaniam
    Wang, Li
    CANCER RESEARCH, 2017, 77
  • [28] The IL-23/IL-17 axis in stable liver transplant recipients
    Fabrega, E.
    Lopez-Hoyos, M.
    San Segundo, D.
    Pons-Romero, F.
    JOURNAL OF HEPATOLOGY, 2008, 48 : S81 - S81
  • [29] Interpreting the Function of the IL-23/IL-17 Axis through Bioinformatics
    Vazquez-Jimenez, Sonia Isela
    Gonzalez-Sanchez, Grecia Denisse
    Guerrero-Velazquez, Celia
    Guzman-Flores, Juan Manuel
    ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, 2024,
  • [30] How Can We Manipulate the IL-23/IL-17 Axis?
    Ling Zhao
    Daniela Ghetie
    Zhenyu Jiang
    Cong-Qiu Chu
    Current Treatment Options in Rheumatology, 2015, 1 (2) : 182 - 196
12345